{
    "initial_questions": "Here are two multiple-choice questions for each Bloom's Taxonomy level:\n\n**Knowledge**\n1) At what age was Stephen Hawking diagnosed with ALS?\n    - A: 18\n    - B: 21\n    - C: 30\n    - D: 40\n[Correct answer]: B\n\n2) What is another name for ALS?\n    - A: Parkinson's Disease\n    - B: Alzheimer's Disease\n    - C: Lou Gehrig's Disease\n    - D: Huntington's Disease\n[Correct answer]: C\n\n**Comprehension**\n1) What is the primary effect of ALS on the body?\n    - A: It affects involuntary muscle control.\n    - B: It affects voluntary muscle control.\n    - C: It affects the cardiovascular system.\n    - D: It affects the respiratory system.\n[Correct answer]: B\n\n2) What happens to motor neurons in ALS patients?\n    - A: They regenerate and multiply.\n    - B: They remain unaffected.\n    - C: They degenerate and disrupt the signaling system.\n    - D: They become stronger and more resilient.\n[Correct answer]: C\n\n**Application**\n1) What is a potential benefit of understanding the causes and effects of ALS?\n    - A: Developing new treatments and therapies.\n    - B: Reducing funding for ALS research.\n    - C: Decreasing awareness about ALS.\n    - D: Limiting healthcare professionals' ability to diagnose ALS.\n[Correct answer]: A\n\n2) How can healthcare professionals use their knowledge of ALS symptoms and progression?\n    - A: To diagnose and care for patients.\n    - B: To develop new drugs and therapies.\n    - C: To raise awareness about ALS.\n    - D: To reduce funding for ALS research.\n[Correct answer]: A\n\n**Analysis**\n1) What is the relationship between the degeneration of motor neurons and the disruption of the signaling system in ALS patients?\n    - A: The degeneration of motor neurons has no effect on the signaling system.\n    - B: The degeneration of motor neurons strengthens the signaling system.\n    - C: The degeneration of motor neurons disrupts the signaling system between the brain and muscles.\n    - D: The degeneration of motor neurons only affects the lower motor neurons.\n[Correct answer]: C\n\n2) What is a key difference between hereditary and sporadic cases of ALS?\n    - A: Hereditary cases are caused by environmental factors, while sporadic cases are caused by genetic mutations.\n    - B: Hereditary cases are caused by genetic mutations, while sporadic cases may be caused by environmental factors or toxins.\n    - C: Hereditary cases are more common than sporadic cases.\n    - D: Sporadic cases are only caused by lifestyle factors.\n[Correct answer]: B\n\n**Synthesis**\n1) How can the understanding of ALS's impact on the neuromuscular system be combined with the development of new treatments and therapies?\n    - A: By focusing solely on the neuromuscular system.\n    - B: By integrating knowledge of the neuromuscular system with the development of new treatments and therapies to slow disease progression.\n    - C: By ignoring the neuromuscular system's role in ALS.\n    - D: By developing treatments that only target the lower motor neurons.\n[Correct answer]: B\n\n2) What is a potential connection between ALS and other neurodegenerative diseases?\n    - A: They are all caused by the same genetic mutation.\n    - B: They all affect the same area of the brain.\n    - C: They may share common underlying mechanisms, such as protein misfolding.\n    - D: They are all curable with the same treatment.\n[Correct answer]: C\n\n**Evaluation**\n1) What is a crucial aspect of evaluating the effectiveness of current treatments and therapies for ALS?\n    - A: Ignoring patient outcomes and focusing solely on the cost of treatment.\n    - B: Considering only the benefits of treatment and ignoring potential risks.\n    - C: Assessing both the benefits and risks of treatment and considering patient outcomes.\n    - D: Evaluating treatment effectiveness based solely on animal studies.\n[Correct answer]: C\n\n2) Why is it essential to justify the need for increased funding and support for ALS research and treatment?\n    - A: Because ALS is a rare disease that affects few people.\n    - B: Because current treatments are sufficient, and no further research is needed.\n    - C: Because ALS is a devastating disease with no cure, and increased funding can accelerate research and improve patient outcomes.\n    - D: Because ALS research is too expensive and not cost-effective.\n[Correct answer]: C"
}